Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| E-mail: | support@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street |
| Product Name | MF | CAS | Details |
|---|
| Euphorbia factor L7a | C33H40O7 | 93550-94-8 | Details |
| Heteroclitin C | C28H34O8 | 140460-42-0 | Details |
| Kansuiphorin C；KPC | C29H34O6 | 133898-77-8 | Details |
| Kushenol M | C30H36O7 | 101236-51-5 | Details |
| Methyl 4-caffeoylquinate | C17H20O9 | 123372-74-7 | Details |
| Methyl salvionolate A | C27H24O10 | 1015171-69-3 | Details |
| Notoginsenoside T5 | C41H68O12 | 769932-34-5 | Details |
| Phyltetralin | C24H32O6 | 123048-17-9 | Details |
| Platycoside M1 | C36H54O12 | 917482-67-8 | Details |
| Sanggenone K | C30H32O6 | 86450-77-3 | Details |
| Sargentol | C17H24O10 | 623928-18-7 | Details |
| Monnieriside G | C21H26O10 | 1401799-34-5 | Details |
| Tegatrabetan；BC2059 | C28H36N4O6S2 | 1227637-23-1 | Details |
| Multi-kinase inhibitor 1；Multi-kinase inhibitor I | C20H17F3N4O3 | 778274-97-8 | Details |
| JNJ-42041935；HIF-PHD Inhibitor II | C12H6ClF3N4O3 | 1193383-09-3 | Details |
| Poricoic acid AM | C32H48O5 | 151200-92-9 | Details |
| CC-115；CC115;CC 115 | C16H16N8O | 1228013-15-7 | Details |
| Givinostat hydrochloride；ITF2357;ITF-2357;ITF2357 hydrochloride;ITF2357 HCl;Givinostat HCl;Givinostat HCl. gavinostat,;ITF 2357 | C24H28ClN3O4 | 199657-29-9 | Details |
| Monomelittoside；Danmelittoside | C15H22O10 | 20633-72-1 | Details |
| PT-2385 | C17H12F3NO4S | 1672665-49-4 | Details |
| Tos-Gly-Pro-Arg-ANBA-IPA acetate；tos-GPR-ANBA-IPA acetate | C32H45N9O10S | 2070009-46-8 | Details |
| Yoda 1 | C13H8Cl2N4S2 | 448947-81-7 | Details |
| MCB-613；MCB 613;MCB613 | C20H20N2O | 1162656-22-5 | Details |
| Oxyresveratrol 3'-O-β-D-glucopyranoside；Oxyresveratrol 3'-O-beta-D-glucopyranoside | C20H22O9 | 144525-40-6 | Details |
| LLY-507；LLY 507;LLY507 | C36H42N6O | 1793053-37-8 | Details |
| Acridan-9-carboxylic acid, 10-methyl-, 2-(diethylamino)ethyl ester, hydrochloride | C21H27ClN2O2 | 69781-84-6 | Details |
| Glycylhydroxyprolylproline；Tripeptide-6 | C12H19N3O5 | 22028-82-6 | Details |
| Olodaterol hydrochloride；BI 1744 hydrochloride;BI-1744 HCl | C21H27ClN2O5 | 869477-96-3 | Details |
| ETC-159；ETC159;ETC-1922159;ETC 159 | C19H17N7O3 | 1638250-96-0 | Details |
| 3,4,5'-Trimethoxy-3',4'-methylenedioxy-7,9':7',9-diepoxylignan | C22H24O7 | 873867-94-8 | Details |
| 4E-Deacetylchromolaenide 4'-O-acetate | C22H28O7 | 104736-09-6 | Details |
| Eupalinolide I | C24H30O9 | 1402067-84-8 | Details |
| Isolupalbigenin | C25H26O5 | 162616-70-8 | Details |
| Sulfidefluor-7 AM | C31H23N7O12 | 1416872-50-8 | Details |
| LJH685 | C22H21F2N3O | 1627710-50-2 | Details |
| AMG9810 | C21H23NO3 | 545395-94-6 | Details |
| 1-Phenylpropane-1,2-dione；Acetyl benzoyl;1-Phenyl-1,2-propanedione | C9H8O2 | 579-07-7 | Details |
| STING agonist-1；G10 | C21H16ClFN2O3S | 702662-50-8 | Details |
| C-DIM12 | C23H17ClN2 | 178946-89-9 | Details |
| Apcin | C13H14Cl3N7O4 | 300815-04-7 | Details |
| G244-LM | C18H22N4O3S2 | 1563007-08-8 | Details |
| Sacubitril sodium；AHU-377;LCZ696;AHU 377;AHU377 | C24H28NNaO5 | 149690-05-1 | Details |
| Pridopidine hydrochloride；Pridopidine HCl;FR310826;ASP-2314 hydrochloride;ASP2314 HCl | C15H24ClNO2S | 882737-42-0 | Details |
| Hecogenin；Hocogenin | C27H42O4 | 467-55-0 | Details |
| 3-O-Acetyl-16α-hydroxytrametenolic acid；3-O-Acetyl-16 alpha-hydroxytrametenolic acid | C32H50O5 | 168293-13-8 | Details |
| Apratoxin B | C44H67N5O8S | 444885-29-4 | Details |
| GSK3326595；EPZ015938 | C24H32N6O3 | 1616392-22-3 | Details |
| Selonsertib；GS-4997 | C24H24FN7O | 1448428-04-3 | Details |
| Orexin 2 Receptor Agonist；OX2R | C32H34N4O5S | 1796565-52-0 | Details |
| ML264；CID-51003603 | C17H21ClN2O4S | 1550008-55-3 | Details |
| GSK481；GSK'481 | C21H19N3O4 | 1622849-58-4 | Details |
| SR-3029；SR3029;SR 3029 | C23H19F3N8O | 1454585-06-8 | Details |
| SU5201；NSC 247030 | C15H9Cl2NO | 114727-43-4 | Details |
| Macozinone；PBTZ169 | C20H23F3N4O3S | 1377239-83-2 | Details |
| Sitravatinib；MG516;MGCD516 | C33H29F2N5O4S | 1123837-84-2 | Details |
| FITM | C18H18FN5OS | 932737-65-0 | Details |
| A-794278 | C18H22N4OS | 869802-57-3 | Details |
| MSC 2032964A；MSC-2032964A;MSC2032964A | C16H13F3N6O | 1124381-43-6 | Details |
| Cadazolid；ACT-179811 | C29H29F2N3O8 | 1025097-10-2 | Details |
| Bufotalin；Bufotaline | C26H36O6 | 471-95-4 | Details |
| Trierucin | C69H128O6 | 2752-99-0 | Details |
| Leptoside | C30H42O10 | 465-68-9 | Details |
| BMS-986176 | C19H23F4N3O | 1815613-42-3 | Details |
| MFCD28987368 | C34H54N4O10 | 1610413-97-2 | Details |
| Ralinepag；APD811 | C23H26ClNO5 | 1187856-49-0 | Details |
| COH29；RNR Inhibitor COH29 | C22H16N2O5S | 1190932-38-7 | Details |
| HAMNO；NSC111847 | C17H13NO2 | 138736-73-9 | Details |
| LDN-193189 2HCl；DM-3189 2HCl | C25H24Cl2N6 | 1435934-00-1 | Details |
| GSK2983559 active metabolite；RIPK2 inhibitor 1;RIPK2-IN-1;GSK2983559 | C21H22N4O4S2 | 1423186-80-4 | Details |
| SZL P1-41 | C24H24N2O3S | 222716-34-9 | Details |
| Acumapimod；BCT-197 | C22H19N5O2 | 836683-15-9 | Details |
| BFH772；BFH-722 | C23H16F3N3O3 | 890128-81-1 | Details |
| CBL0137 hydrochloride；CBLC137;CBL0137;Curaxin-137 hydrochloride;CBL-C137 hydrochloride;Curaxin 137 | C21H25ClN2O2 | 1197397-89-9 | Details |
| NSC23005 Sodium | C13H18NNaO4S | 1796596-46-7 | Details |
| Azido-PEG12-t-butyl ester | C31H62N3O14 | 1818294-45-9 | Details |
| Futibatinib；FGFR-IN-1;TAS120 | C22H22N6O3 | 1448169-71-8 | Details |
| β-Gentiobiose | C12H22O11 | 554-91-6 | Details |
| 25(S)-Ruscogenin-1-O-α-L-rhamnopyranosyl (1→2)-β-D-xylopyranoside；(1beta,3beta,25S)-3-Hydroxyspirost-5-en-1-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-xylopyranoside | C38H60O12 | 125225-63-0 | Details |
| Rotundatin | C15H14O4 | 144506-16-1 | Details |
| Avacopan；CCX168 | C33H35F4N3O2 | 1346623-17-3 | Details |
| Exeporfinium chloride；XF 73;XF73;XF-73 | C44H50Cl2N6O2 | 718638-68-7 | Details |
| Axelopran；TD-1211;TD1211;TD 1211 | C26H39N3O4 | 949904-48-7 | Details |
| PNU-200579；PNU 200579;PNU200579 | C22H29NO3 | 194482-44-5 | Details |
| GJ103 | C16H14N4O3S | 1459687-89-8 | Details |
| S1p receptor agonist 1；S1p-receptor-agonist-1 | C23H24FN3O3 | 1514888-56-2 | Details |
| GSK-872；GSK2399872A;GSK'872;GSK872 | C19H17N3O2S2 | 1346546-69-7 | Details |
| Roblitinib；FGF-401 | C25H30N8O4 | 1708971-55-4 | Details |
| VA5 TG2 inhibitor；VA-5;VA 5;VA5 | C31H34N4O8 | 2088001-24-3 | Details |
| Lys05；Lys01 trihydrochloride | C23H24Cl3N5 | 1391426-24-6 | Details |
| Pimodivir；VX-787 | C20H19F2N5O2 | 1629869-44-8 | Details |
| Leptine I, from Solanum chacoense；Leptine I | C47H75NO16 | 101030-83-5 | Details |
| Yadanzioside K | C36H48O18 | 101559-98-2 | Details |
| Nanterinone mesylate；UK61260;UK 61260;UK-61260 | C16H19N3O4S | 102791-74-2 | Details |
| Monoethyl itaconate | C7H10O4 | 57718-07-7 | Details |
| Dobutamine lactobionate | C30H45NO15 | 104564-71-8 | Details |
| Lanost-7,9(11)-diene-3,24,25-triol-, (3beta,24S)- | C30H50O3 | 107900-79-8 | Details |
| Clodronic acid disodium salt；Loron;Lodronate;Clodronate Disodium | CH5Cl2NaO6P2 | 22560-50-5 | Details |
| AT 4930；AT4930;AT-4930 | C19H23FN4O3 | 123016-40-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 | ||||